Galatea Kallergi

14PUBLICATIONS
28CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jun 03, 2026
Repurposing Artesunate to Combat Progression and Metastasis via Targeting Circulating Tumor Cells.

|May 13, 2026
The HGF/MET Axis in Advanced Prostate Cancer: From Context-Dependent Biology to Biomarker-Driven Therapeutic Strategies.

|Feb 18, 2026
Metabolic marker profiling of circulating tumour cells in NSCLC patients treated with osimertinib: focus on MCT1 and MCT4.

Karolina Mangani, Evangelia Pantazaka, Evi Lianidou

|Jan 28, 2026
Combinatorial Analysis of CD4+Tregs, CD8+Teffs, and Inflammatory Indices Predict Response to ICI in ES-SCLC Patients.

Anastasia Xagara, Konstantinos Tsapakidis, Vassileios Papadopoulos

|Nov 22, 2024
Integrative analysis of circulating tumor cells (CTCs) and exosomes from small-cell lung cancer (SCLC) patients: a comprehensive approach.

Dimitrios Papakonstantinou, Argyro Roumeliotou, Evangelia Pantazaka

|May 10, 2024
Comprehensive Analysis of CXCR4, JUNB, and PD-L1 Expression in Circulating Tumor Cells (CTCs) from Prostate Cancer Patients.

Argyro Roumeliotou, Areti Strati, Foteini Chamchougia

Pageof 3

Frequent Collaborators

10 joint publications

Athanasios Κotsakis

5 joint publications

Vassilis Georgoulias

5 joint publications

Evangelia Pantazaka

4 joint publications

Anastasia Xagara